dbo:abstract
|
- بي أف-592,379 (بالإنجليزية: PF-592,379) هو دواء طورته فايزر وهو قوي وانتقائي . الدواء تحت الدراسة بسبب احتمال فعاليته في علاج وضعف الانتصاب عند الرجال. بخلاف ناهضات مستقبل الدوبامين د3 الانتقائية الأخرى، لم تظخر هذه المادة سوء استخدام محتمل. (ar)
- PF-592,379 is a drug developed by Pfizer which acts as a potent, selective and orally active agonist for the dopamine D3 receptor, which is under development as a potential medication for the treatment of female sexual dysfunction and male erectile dysfunction. Unlike some other less selective D3 agonists, a research study showed that PF-592,379 has little abuse potential in animal studies, and so was selected for further development and potentially human clinical trials. Development has since been discontinued. (en)
|
dbo:casNumber
| |
dbo:fdaUniiCode
| |
dbo:pubchem
| |
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 3385 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chemspiderid
| |
dbp:h
| |
dbp:iupacName
| |
dbp:iupharLigand
| |
dbp:legalStatus
| |
dbp:n
| |
dbp:o
| |
dbp:pubchem
| |
dbp:routesOfAdministration
| |
dbp:smiles
|
- CCCNC[C@H]1C2=CN=CC=C2 (en)
|
dbp:stdinchi
| |
dbp:stdinchikey
|
- DFTCYTDJDXZFSK-JQWIXIFHSA-N (en)
|
dbp:unii
| |
dbp:width
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- بي أف-592,379 (بالإنجليزية: PF-592,379) هو دواء طورته فايزر وهو قوي وانتقائي . الدواء تحت الدراسة بسبب احتمال فعاليته في علاج وضعف الانتصاب عند الرجال. بخلاف ناهضات مستقبل الدوبامين د3 الانتقائية الأخرى، لم تظخر هذه المادة سوء استخدام محتمل. (ar)
- PF-592,379 is a drug developed by Pfizer which acts as a potent, selective and orally active agonist for the dopamine D3 receptor, which is under development as a potential medication for the treatment of female sexual dysfunction and male erectile dysfunction. Unlike some other less selective D3 agonists, a research study showed that PF-592,379 has little abuse potential in animal studies, and so was selected for further development and potentially human clinical trials. Development has since been discontinued. (en)
|
rdfs:label
|
- بي أف-592379 (ar)
- PF-592,379 (en)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |